Cargando…
The Role of EGFR Inhibitors in the Treatment of Metastatic Anal Canal Carcinoma: A Case Series
Anal cancer patients who have exhibited disease progression after having received all approved drugs pose a major therapeutic challenge. In addition to cytotoxic agents, novel targeted agents are being developed and have an established role in the treatment of many solid tumors, including colon canc...
Autores principales: | Saif, Muhammad W., Kontny, Ewa, Syrigos, Kostas N., Shahrokni, Armin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3136097/ https://www.ncbi.nlm.nih.gov/pubmed/21772841 http://dx.doi.org/10.1155/2011/125467 |
Ejemplares similares
-
IAP inhibitor plus chemoradiotherapy for the treatment of bulky anal canal carcinoma
por: De Felice, Francesca, et al.
Publicado: (2023) -
Mitomycin and 5‐fluorouracil for second‐line treatment of metastatic squamous cell carcinomas of the anal canal
por: Saint, Angélique, et al.
Publicado: (2019) -
EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
por: Paliga, A, et al.
Publicado: (2012) -
Melanoma of the anal canal
por: Parra, Rogerio Serafim, et al.
Publicado: (2010) -
Role of Vitamin D in the Prevention of Pancreatic Cancer
por: Bulathsinghala, Pubudu, et al.
Publicado: (2010)